Josef Rauschecker mentioned intravenous Lidocaine again and potentially similar drugs but with a prolonged effect, in the new Tinnitus Talk interview at Patreon. In my opinion he made it sound rather appealing, but what about the ototoxicity?
Lidocaine is used to treat ear infections, I'm using it right now in the form of ear drops. Not sure how different it is to IV.Josef Rauschecker mentioned intravenous Lidocaine again and potentially similar drugs but with a prolonged effect, in the new Tinnitus Talk interview at Patreon. In my opinion he made it sound rather appealing, but what about the ototoxicity?
I suppose that the difference is that, as an IV, Lidocaine gets into your blood stream, and therefore can reach your cochlea.Lidocaine is used to treat ear infections, I'm using it right now in the form of ear drops. Not sure how different it is to IV.
There is a warning on the bottle not to use it if you have a perforated eardrum alright.As ear drops, it is called topical application and, unless you have a perforated ear drum, the drops will be prevented from making their way from the canal to the middle ear, so they are unlikely to get anywhere near your cochlea.
Interesting. I will look for the studies. I thought only Lidocaine worked.There seems to be two Lidocaine derivatives that could be taken orally. Mexiletine and Tocainide. Both have been trailed heavily in the 80s and 90s with rather good results but due to the effect being only temporary it was not worth the risk as these drugs can not be taken long term. I guess this is why those drugs never got approved as a tinnitus treatment.
Did you find any studies?Interesting. I will look for the studies. I thought only Lidocaine worked.
Only intravenous Lidocaine and the ear shots in another thread.Did you find any studies?
Does anyone have the full paper?Unexpectedly, a substantial number of tinnitus patients reported a worsening of their tinnitus, forcing a revision of our analytical strategy.
Here it is.Does anyone have the full paper?
Yes, Massachusetts Eye & Ear is recruiting for the following "exploratory pilot open-label study". I will be very interested to see the results.I think there is a current trial in America using Lidocaine whilst measuring brain activity. It's on Tinnitus Talk somewhere.
This study finished 8 months ago:
→ Action of Intra-auricular Topical Lidocaine on Tinnitus[/Q
This is interesting. It is an easy-to-perform procedure. They still seem to be reviewing the results.I think there is a current trial in America using Lidocaine whilst measuring brain activity. It's on Tinnitus Talk somewhere.
This study finished 8 months ago:
→ Action of Intra-auricular Topical Lidocaine on Tinnitus
Interesting, but what if (some specific) tinnitus is neuropathy?Yes, Massachusetts Eye & Ear is recruiting for the following "exploratory pilot open-label study". I will be very interested to see the results.
→ An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
fMRI and other brain imaging technologies measure indices of brain activity that can provide information about nociception and, by inference, pain, but brain imaging data can only be a proxy measure of pain.
Thanks for sharing. I emailed them to see if they're taking more participants for the "normal hearing (NH) with tinnitus (T+)" cohort. I'd fly up to Boston for this in a heartbeat. It seems like a small study, though. 40 participants total, only some of whom actually have tinnitus.Yes, Massachusetts Eye & Ear is recruiting for the following "exploratory pilot open-label study". I will be very interested to see the results.
→ An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
Thank you for reaching out with your interest in this study. My name is Mikayla Day, and I am a clinical research assistant in Dr. Simonyan's lab at Mass. Eye and Ear.
In summary, our Lidocaine on Tinnitus Study is a two-day back-to-back study that includes baseline questionnaires, a blood draw and EKG, a hearing test, and an MRI. All these procedures (except the EKG) are then repeated on the second day after the lidocaine infusion. Please note that all these procedures are for research purposes only, meaning there is no guarantee of relief of tinnitus symptoms from the infusion, nor can lidocaine be prescribed as a treatment option for tinnitus.
In addition to this study, we are recruiting interested volunteers in another tinnitus study that overlaps with the above study procedures. If you are interested, the only extra testing would be an additional MRI and a 10-minute MEG.
One hundred milligrams of Lidocaine given intravenously quickly reduced the pitch of his tinnitus in the left ear but did not change the loudness. The right ear remained unchanged.
Too bad the paper is behind a paywall.Various ion channels and receptors (e.g. voltage-gated Na(+), K(+) and Ca(2+) channels, glutamate, GABA, glycine and vanilloid receptors), found in the auditory system and possibly connected to tinnitus, are affected by lidocaine.
Attached is the full paper.Another Lidocaine study.
But the previous paper also stated that Lidocaine does not cross the blood-labyrinth barrier (BLB). How can we then get these results?Intravenous lidocaine injection resulted in suppression of tinnitus in 22 (73%) ears, and changes of EOAE amplitude (increase or decrease) in 18 (60%) ears. Of the 18 ears with EOAE amplitude changes, tinnitus disappeared or decreased in 17 (94%) ears. In 12 ears without changes of EOAE amplitude, tinnitus was suppressed in only 5 (42%).
Attached is the full paper of that one, too.Here is another paper that is referenced in the previous one. For some, Lidocaine seems to have an effect (and in the cochlea). It would be interesting to know the cause of the patients' tinnitus. But again, this paper is behind a paywall, and this information will probably not be available.
But the previous paper also stated that Lidocaine does not cross the blood-labyrinth barrier (BLB). How can we then get these results?
I'm not an expert, but maybe Lidocaine blocks HCN2 channels in auditory nerve fibers.How can we then get these results?